The Infectious Disease Diagnostics Market size is expected to grow at an annual average of 6% during 2021-2027. The epidemiological burden of infectious diseases such as Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS), Ebola, Chikungunya, Bird Flu, Swine Flu and Zika has opened the door for early diagnosis and prevention. Similarly, the current Corona 19 outbreak has dramatically increased the demand for various POC diagnostic kits to control the early diagnosis and spread of the coronavirus.
(Get 15% Discount on Buying this Report)
A full report of Infectious Disease Diagnostics Market is available at: https://www.orionmarketreports.com/infectious-disease-diagnostics-market/26612/
The following segmentation are covered in this report:
By Product
- Reagents, Kits, and Consumables
- Instruments
- Software & Services
By Type of Testing
- Laboratory Testing
- POC Testing
By Technology
- Immunodiagnostics
- Clinical Microbiology
- PCR
- INAAT
- DNA Sequencing & NGS
- DNA Microarrays
- Other technologies
Company Profile
- Biomérieux SA
- Abbott Laboratories
- Becton, Dickinson and Company
- Bio-Rad Laboratories
- Danaher Corporation
- Hoffmann-La Roche AG
- Siemens Healthineers
- Thermo Fisher Scientific
The report covers the following objectives:
- Proliferation and maturation of trade in the global Infectious Disease Diagnostics Market
- The market share of the global Infectious Disease Diagnostics Market supply and demand ratio, growth revenue, supply chain analysis, and business overview.
- Current and future market trends that are influencing the growth opportunities and growth rate of the Infectious Disease Diagnostics Market
- Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Infectious Disease Diagnostics Market
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
